Response to Tenofovir Among Lamivudine-experienced Hepatitis B and HIV-coinfected Adolescents
Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. We determined hepatitis B virus (HBV) suppression rates among 18 lamivudine (3TC)-experienced HBV-human immunodeficiency virus-coinfected adolescents after treatment with tenofovir disoproxil fumurate (TDF). At TDF initiation, their m...
Saved in:
Main Authors: | Aurpibul L., Lumbiganon P., Hansudewechakul R., Kanjanavanit S., Bunupuradah T., Kosalaraksa P., Taeprasert P., Puthanakit T. |
---|---|
Format: | Journal |
Published: |
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85007247655&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/40623 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Response to Tenofovir Among Lamivudine-experienced Hepatitis B and HIV-coinfected Adolescents
by: Linda Aurpibul, et al.
Published: (2018) -
Response to Tenofovir Among Lamivudine-experienced Hepatitis B and HIV-coinfected Adolescents
by: Linda Aurpibul, et al.
Published: (2018) -
HIV and hepatitis B coinfection among perinatally HIV-infected thai adolescents
by: Aurpibul L., et al.
Published: (2017) -
HIV and hepatitis B coinfection among perinatally HIV-infected thai adolescents
by: Linda Aurpibul, et al.
Published: (2018) -
Risk of Liver Fibrosis in Hepatitis B Virus and HIV Coinfected Youths Receiving Tenofovir-Containing Antiretroviral Regimen
by: Linda Aurpibul, et al.
Published: (2019)